These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 17507611)

  • 1. Is TGFBR1*6A a susceptibility allele for nonsyndromic familial colorectal neoplasia?
    Daley D; Morgan W; Lewis S; Willis J; Elston RC; Markowitz SD; Wiesner GL
    Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):892-4. PubMed ID: 17507611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of an association between the TGFBR1*6A variant and colorectal cancer risk.
    Skoglund J; Song B; Dalén J; Dedorson S; Edler D; Hjern F; Holm J; Lenander C; Lindforss U; Lundqvist N; Olivecrona H; Olsson L; Påhlman L; Rutegård J; Smedh K; Törnqvist A; Houlston RS; Lindblom A
    Clin Cancer Res; 2007 Jun; 13(12):3748-52. PubMed ID: 17575241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGFBR1*6A and cancer risk: a meta-analysis of seven case-control studies.
    Kaklamani VG; Hou N; Bian Y; Reich J; Offit K; Michel LS; Rubinstein WS; Rademaker A; Pasche B
    J Clin Oncol; 2003 Sep; 21(17):3236-43. PubMed ID: 12947057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGFBR1(*)6A and Int7G24A variants of transforming growth factor-beta receptor 1 in Swedish familial and sporadic breast cancer.
    Song B; Margolin S; Skoglund J; Zhou X; Rantala J; Picelli S; Werelius B; Lindblom A
    Br J Cancer; 2007 Oct; 97(8):1175-9. PubMed ID: 17848956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined genetic assessment of transforming growth factor-beta signaling pathway variants may predict breast cancer risk.
    Kaklamani VG; Baddi L; Liu J; Rosman D; Phukan S; Bradley C; Hegarty C; McDaniel B; Rademaker A; Oddoux C; Ostrer H; Michel LS; Huang H; Chen Y; Ahsan H; Offit K; Pasche B
    Cancer Res; 2005 Apr; 65(8):3454-61. PubMed ID: 15833881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TbetaR-I(6A) is a candidate tumor susceptibility allele.
    Pasche B; Kolachana P; Nafa K; Satagopan J; Chen YG; Lo RS; Brener D; Yang D; Kirstein L; Oddoux C; Ostrer H; Vineis P; Varesco L; Jhanwar S; Luzzatto L; Massagué J; Offit K
    Cancer Res; 1999 Nov; 59(22):5678-82. PubMed ID: 10582683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms in the transforming growth factor beta 1 pathway in relation to colorectal cancer progression.
    Försti A; Li X; Wagner K; Tavelin B; Enquist K; Palmqvist R; Altieri A; Hallmans G; Hemminki K; Lenner P
    Genes Chromosomes Cancer; 2010 Mar; 49(3):270-81. PubMed ID: 19998449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TGFBR1 variants TGFBR1(*)6A and Int7G24A are not associated with an increased familial colorectal cancer risk.
    Skoglund Lundin J; Vandrovcova J; Song B; Zhou X; Zelada-Hedman M; Werelius B; Houlston RS; Lindblom A
    Br J Cancer; 2009 May; 100(10):1674-9. PubMed ID: 19401691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The TGFBR1*6A allele is not associated with susceptibility to colorectal cancer in a Spanish population: a case-control study.
    Castillejo A; Mata-Balaguer T; Montenegro P; Ochoa E; Lázaro R; Martínez-Cantó A; Castillejo MI; Guarinos C; Barberá VM; Guillén-Ponce C; Carrato A; Soto JL
    BMC Cancer; 2009 Jun; 9():193. PubMed ID: 19538729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatic acquisition and signaling of TGFBR1*6A in cancer.
    Pasche B; Knobloch TJ; Bian Y; Liu J; Phukan S; Rosman D; Kaklamani V; Baddi L; Siddiqui FS; Frankel W; Prior TW; Schuller DE; Agrawal A; Lang J; Dolan ME; Vokes EE; Lane WS; Huang CC; Caldes T; Di Cristofano A; Hampel H; Nilsson I; von Heijne G; Fodde R; Murty VV; de la Chapelle A; Weghorst CM
    JAMA; 2005 Oct; 294(13):1634-46. PubMed ID: 16204663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The chromosome 9q genes TGFBR1, TSC1, and ZNF189 are rarely mutated in bladder cancer.
    van Tilborg AA; de Vries A; Zwarthoff EC
    J Pathol; 2001 May; 194(1):76-80. PubMed ID: 11329144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TGFBR1*6A and cancer: a meta-analysis of 12 case-control studies.
    Pasche B; Kaklamani V; Hou N; Young T; Rademaker A; Peterlongo P; Ellis N; Offit K; Caldes T; Reiss M; Zheng T
    J Clin Oncol; 2004 Feb; 22(4):756-8. PubMed ID: 14966109
    [No Abstract]   [Full Text] [Related]  

  • 13. Int7G24A variant of the TGFBR1 gene and cancer risk: a meta-analysis of three case-control studies.
    Zhang HT
    Lung Cancer; 2005 Sep; 49(3):419-20. PubMed ID: 15955593
    [No Abstract]   [Full Text] [Related]  

  • 14. No association between TGFBR1*6A and lung cancer.
    You W; Liu Z; Zhao J; Zheng M; Zheng SY; Liu X; Zhang HT
    J Thorac Oncol; 2007 Jul; 2(7):657-9. PubMed ID: 17607123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioinformatic and functional analysis of TGFBR1 polymorphisms.
    Schirmer MA; Hoffmann AO; Campean R; Janke JH; Zidek LM; Hoffmann M; Kruse M; Sehrt D; Tzvetkov MV; Rave-Fränk M; Brockmöller J
    Pharmacogenet Genomics; 2009 Apr; 19(4):249-59. PubMed ID: 19214138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. May TGFBR1 act also as low penetrance allele in Marfan syndrome?
    Lucarini L; Evangelisti L; Attanasio M; Lapini I; Chiarini F; Porciani MC; Abbate R; Gensini G; Pepe G
    Int J Cardiol; 2009 Jan; 131(2):281-4. PubMed ID: 17936924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Little evidence for association between the TGFBR1*6A variant and colorectal cancer: a family-based association study on non-syndromic family members from Australia and Spain.
    Ross JP; Lockett LJ; Tabor B; Saunders IW; Young GP; Macrae F; Blanco I; Capella G; Brown GS; Lockett TJ; Hannan GN
    BMC Cancer; 2014 Jul; 14():475. PubMed ID: 24981199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No major association between TGFBR1*6A and prostate cancer.
    Kaklamani V; Baddi L; Rosman D; Liu J; Ellis N; Oddoux C; Ostrer H; Chen Y; Ahsan H; Offit K; Pasche B
    BMC Genet; 2004 Sep; 5():28. PubMed ID: 15385056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association of polymorphisms on TGFBR1 and colorectal cancer risk: a meta-analysis.
    Zhang X; Wu L; Sheng Y; Zhou W; Huang Z; Qu J; Gao G; Cai D; Zhang M
    Mol Biol Rep; 2012 Mar; 39(3):2567-74. PubMed ID: 21858550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assignment of human transforming growth factor-beta type I and type III receptor genes (TGFBR1 and TGFBR3) to 9q33-q34 and 1p32-p33, respectively.
    Johnson DW; Qumsiyeh M; Benkhalifa M; Marchuk DA
    Genomics; 1995 Jul; 28(2):356-7. PubMed ID: 8530052
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.